Several leading scientists and oncologists have announced a major breakthrough in treating cancer with the “wonder drug” ivermectin.
The combination of fenbendazole and ivermectin as an alternative cancer therapy is giving new hope to doctors and patients alike.
Originally developed as antiparasitic medications, both drugs have demonstrated remarkable off-label effects that may be key in the fight against cancer.
Fenbendazole is commonly used to treat parasitic infections in animals.
It has shown promising results in preclinical studies for its ability to suppress cancer cell growth.
It works by disrupting the microtubules in cancer cells.
The drug essentially breaks down the structure cancer cells need to divide and spread.
By interfering with cell division, fenbendazole starves the cancerous cells of their ability to multiply, leading to their eventual death.
Studies from various sources, including recent research published on PubMed Central, highlight fenbendazole’s cytotoxic effects against multiple types of cancer cells.
It seems to operate similarly to established chemotherapy agents, yet it is far less toxic to healthy cells in the body.
During the COVID-19 pandemic, ivermectin gained significant attention for its potential as an antiviral.
However, it has also been studied for its anti-cancer properties.
Ivermectin induces apoptosis (programmed cell death) in cancer cells by interfering with the WNT-TCF signaling pathway, which is often hyperactivated in cancers.
When cancer cells lose this pathway, they lose their ability to grow and spread uncontrollably.
What makes the combination of fenbendazole and ivermectin so interesting is their potential synergy.
Used together, they provide a multi-faceted attack on cancer cells by targeting different cellular processes.
Ivermectin disrupts cancer cell signaling pathways, while fenbendazole destabilizes cancer cell structure.
This combination could lead to more effective cancer treatments than either drug alone.
Moreover, when paired with other compounds like quercetin, curcumin, and vitamins C and D, these drugs could offer a highly effective, low-cost treatment.
The beauty of this combination lies in its affordability and accessibility, especially since both fenbendazole and ivermectin are off-patent, making them cheaper than conventional cancer treatments.
While the efficacy of these drugs is exciting, there are significant challenges to their mainstream adoption.
One primary hurdle is that these are generic, off-patent drugs, which means there’s little financial incentive for pharmaceutical companies to invest in large-scale clinical trials.
This lack of profitability makes it difficult for these treatments to gain the same level of research and approval as newer, more expensive treatments.
Nevertheless, the success stories of patients using these drugs off-label have garnered a considerable following online.
Advocacy groups, support networks, and alternative medicine enthusiasts have championed the use of fenbendazole and ivermectin, often citing anecdotal evidence and small-scale studies.
While mainstream medical communities may not yet fully embrace the combination of fenbendazole and ivermectin for cancer treatment, growing interest from both patients and researchers suggests that this could be a viable alternative.
These low-cost, widely available medications could provide significant relief for cancer patients, particularly when traditional treatments have failed or are inaccessible.
Further research is needed to conclusively determine the effectiveness of this combination therapy, but the early signs are promising.
It’s clear that fenbendazole and ivermectin deserve a closer look in the ongoing fight against cancer.
For more in-depth scientific insights, you can always check out research articles such as the one found at PubMed Central for further reading.
It comes as oncologists continue to report remarkable results from using ivermectin to treat cancer.
As Slay News reported, renowned surgical oncologist Dr. Kathleen Ruddy has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.
Ruddy told the story of one patient who had reached the end of the road after cancer treatments couldn’t do anything more to help him.
He had stage four prostate cancer and tried all the conventional protocols before doctors told him that there was nothing they could do.
Then, he started taking ivermectin.
Within six months, the metastatic lesions began to disappear.
In under a year, “he was out dancing for four hours” three nights per week, according to Dr. Ruddy.
A similar scenario unfolded for another patient named Eddie, Ruddy revealed.
He was also in bad shape.
Eddie was diagnosed with two unresectable esophageal tumors that surgeons wouldn’t go near.
He was a smoker, couldn’t swallow, and had lost 40 pounds in a year and a half.
“Within a couple of weeks, he sounded stronger. He could swallow,” reported Dr. Ruddy.
“He had gained six pounds. His voice was better.”
Several weeks later, Dr. Ruddy said to Eddie, “You need to get a scan.”
“We got the scan. No tumors. Gone. Gone,” Dr. Ruddy said with astonishment.
“The problem was that he had sold his fishing boat.
“That was the biggest problem. He was getting better. His tumor was gone.”
Ruddy said several other patients have also been treated with ivermectin and they all made miraculous recoveries.
It was at this point that Ruddy said she needed to raise the alert about the success of the drug.
“I was as astonished as anyone might be that ivermectin has potential as an anti-cancer agent,” says Ruddy.
She noted that the probably of the patients recovering coincidentally while taking ivermectin was “zero”
“It’s like winning the lottery on the first three tickets you ever buy,” she explained.
WATCH: Click on the 'text' at the top of the video block to view...
Meanwhile, a recent study found that ivermectin can successfully treat several different forms of cancer.
As Slay News reported, the major study confirmed ivermectin is successful in treating multiple cancers after testing its use against 28 types of the disease.
The researchers sought to identify the effectiveness of using ivermectin as a cancer treatment.
The study found that ivermectin was successful in treating all of the cancers it was tested against.
While some cancers were more resistant to ivermectin than others, the drug still proved at least useful and also helped to improve the effectiveness of chemotherapy.
The most sensitive cancer cell lines were:
- Ovarian
- Breast
- Glioblastoma
- Lung Cancer
- Colon Cancer
- Uterine SCC
- hepatocellular
- breast TNBC
- Pancreatic
- Endometrial
The least sensitive were:
- osteosarcoma
- gastric
- melanoma
Ivermectin was found to be useful in treating both lymphomas and leukemias.
No comments:
Post a Comment